Beaumont Financial Partners, LLC / ABT
Beaumont Financial Partners, LLC’s Abbott Laboratories Position
Does Beaumont Financial Partners, LLC own Abbott Laboratories (ABT)? Yes — 108.3K shares worth $10M (+1.01% of its 13F portfolio) as of Q3 2022, up from 108.3K shares the prior filed quarter.
Position Value
$10M
Q3 2022
Shares
108.3K
% of Portfolio
+1.01%
Quarters Held
16
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 108.3K | $10M | +1.01% |
| Q2 2022 | 108.3K | $12M | +1.06% |
| Q1 2022 | 108.9K | $13M | +0.98% |
| Q4 2021 | 109.2K | $15M | +1.12% |
| Q3 2021 | 111.3K | $13M | +1.01% |
| Q2 2021 | 113.1K | $13M | +1.00% |
| Q1 2021 | 110.9K | $13M | +1.13% |
| Q4 2020 | 111.2K | $12M | +1.08% |
| Q3 2020 | 119.5K | $13M | +1.24% |
| Q2 2020 | 121.0K | $11M | +1.16% |
| Q1 2020 | 118.5K | $9M | +1.18% |
| Q4 2019 | 121.3K | $11M | +1.04% |
| Q3 2019 | 120.0K | $10M | +1.00% |
| Q2 2019 | 120.0K | $10M | +1.04% |
| Q1 2019 | 117.8K | $9M | +1.01% |
| Q4 2018 | 118.9K | $9M | +1.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beaumont Financial Partners, LLC’s full portfolio or all institutional holders of ABT.